| Index | — | P/E | 11.75 | EPS (ttm) | 0.95 | Insider Own | 14.30% | Shs Outstand | 49.39M | Perf Week | 5.78% |
| Market Cap | 551.16M | Forward P/E | 7.24 | EPS next Y | 1.54 | Insider Trans | 0.30% | Shs Float | 42.19M | Perf Month | -0.18% |
| Enterprise Value | 1.64B | PEG | — | EPS next Q | 0.37 | Short Float | 1.57% | Perf Quarter | -10.43% | ||
| Income | 48.00M | P/S | 3.97 | EPS this Y | -8.38% | Short Ratio | 3.20 | Perf Half Y | -24.70% | ||
| Sales | 139.00M | P/B | 0.65 | EPS next Y | -2.63% | ROA | 2.36% | Short Interest | 664.37K | Perf YTD | -16.34% |
| Book/sh | 17.19 | P/C | 110.28 | EPS next 5Y | -3.46% | ROE | 5.40% | 52W High | 15.07 -25.95% | Perf Year | -22.77% |
| Cash/sh | 0.10 | P/FCF | 4.83 | EPS past 3/5Y | 20.66% 24.77% | ROIC | 3.18% | 52W Low | 10.31 8.24% | Perf 3Y | — |
| Dividend Est. | 1.52 (13.62%) | EV/EBITDA | 25.95 | Sales past 3/5Y | 62.59% 86.30% | Gross Margin | 58.26% | Volatility | 2.59% 2.50% | Perf 5Y | — |
| Dividend TTM | 1.61 (14.43%) | EV/Sales | 11.76 | EPS Y/Y TTM | -53.75% | Oper. Margin | 45.71% | ATR (14) | 0.29 | Perf 10Y | — |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | — | Sales Y/Y TTM | -29.08% | Profit Margin | 33.85% | RSI (14) | 54.21 | Recom | 2.60 |
| Dividend Gr. 3/5Y | — | Current Ratio | — | EPS Q/Q | -10.87% | SMA20 | 3.96% | Beta | 0.54 | Target Price | 12.50 |
| Payout | 184.60% | Debt/Eq | 1.28 | Sales Q/Q | -13.16% | SMA50 | -3.29% | Rel Volume | 2.19 | Prev Close | 11.10 |
| Employees | — | LT Debt/Eq | 1.28 | Earnings | Nov 03 | SMA200 | -12.54% | Avg Volume | 229.26K | Price | 11.16 |
| IPO Date | Jan 25, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 4.97% -5.12% | Net Debt/EBITDA | 17.21 | Volume | 502,295 | Change | 0.54% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-01-26 | Upgrade | UBS | Neutral → Buy | $15 → $13 |
| Jun-12-26 | Downgrade | Wells Fargo | Equal Weight → Underweight | $12 |
| May-18-26 | Reiterated | UBS | Neutral | $16 → $15 |
| Apr-20-26 | Reiterated | UBS | Neutral | $15 → $16 |
| Oct-14-25 | Reiterated | UBS | Neutral | $19 → $15 |
| Jul-18-24 | Reiterated | UBS | $18 → $19 | |
| Feb-28-24 | Upgrade | JMP Securities | Market Perform → Market Outperform |
Nuveen Churchill Direct Lending Corp. (NCDL), initially formed as a Delaware limited liability company on March 13, 2018, and subsequently restructured into a Maryland corporation on June 18, 2019, prior to commencing its business activities, operates as a closed-end, externally managed, non-diversified investment company. It has chosen to be regulated as a Business Development Company (BDC) under the Investment Company Act of 1940, as amended. The firm's principal investment goal is to generate appealing risk-adjusted returns, primarily through current income. This is achieved by predominantly investing in senior secured loans provided to private equity-backed U.S. middle market companies, which NCDL identifies as enterprises with annual earnings before interest, taxes, depreciation, and amortization (EBITDA) generally ranging from $10.0 million to $100.0 million. Its portfolio will largely comprise what it refers to as "Senior Loans," primarily consisting of privately originated first-lien senior secured debt and unitranche loans (excluding "last-out" positions) to these performing U.S. middle market businesses. Additionally, the company selectively pursues "Junior Capital Investments," which include instruments such as second-lien loans, subordinated debt, last-out unitranche loan positions, and various equity-related securities.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 139 | 202 | 186 | 144 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 57 | 31 | 75 | 58 | — | — | — | — | — | |
| Gross Profit | 82 | 171 | 111 | 86 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 8 | 8 | 7 | 6 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 9 | 20 | -12 | 3 | — | — | — | — | — | |
| Operating Income | 63 | 144 | 116 | 77 | — | — | — | — | — | |
| Interest Expense | 68 | 78 | 80 | 61 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 51 | 0 | 80 | 61 | — | — | — | — | — | |
| Net Income Before Taxes | 47 | 66 | 116 | 77 | — | — | — | — | — | |
| Income Taxes | -1 | 0 | 0 | 1 | — | — | — | — | — | |
| Consolidated Net Income | 48 | 66 | 116 | 76 | — | — | — | — | — | |
| Net Income From Continuing Operations | 48 | 66 | 116 | 76 | — | — | — | — | — | |
| Net Income | 48 | 66 | 116 | 76 | — | — | — | — | — | |
| EPS (Recurring) | 0.95 | 1.30 | 2.15 | 2.27 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.95 | 1.30 | 2.15 | 2.27 | — | — | — | — | — | |
| EPS (Diluted) | 0.95 | 1.30 | 2.15 | 2.27 | — | — | — | — | — | |
| EBITDA | 63 | 144 | 116 | 77 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 11.75 | 10.26 | 7.80 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.93 | 3.30 | 4.87 | — | — | — | — | — | — | |
| Gross Margin | 58.99 | 84.65 | 59.68 | 59.72 | — | — | — | — | — | |
| Operating Margin | 45.32 | 71.29 | 62.37 | 53.47 | — | — | — | — | — | |
| Net Margin | 34.53 | 32.67 | 62.37 | 52.78 | — | — | — | — | — | |
| Shares Outstanding | 49 | 50 | 54 | 33 | — | — | — | — | — | |
| Market Capitalization | 547 | 667 | 906 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Vichness Shaul | Chief Financial Off./Treasurer | Sep 14 '26 | Buy | 12.25 | 5,000 | 61,250 | 36,647 | Sep 15 |
| McCally John | Vice President & Secretary | May 15 '26 | Buy | 13.27 | 7,500 | 99,525 | 15,245 | Jun 24 |
| Vichness Shaul | Chief Financial Off./Treasurer | May 14 '26 | Buy | 13.20 | 5,000 | 66,000 | 30,705 | May 15 |
| Hassen Marissa | Chief Accounting Officer | May 12 '26 | Buy | 13.21 | 3,782 | 49,960 | 9,780 | May 13 |
| Vichness Shaul | Chief Financial Off./Treasurer | Mar 12 '26 | Buy | 13.13 | 5,000 | 65,650 | 25,000 | Mar 12 |
| RITCHIE JAMES JOSEPH | Director | Mar 10 '26 | Buy | 13.71 | 17,857 | 244,819 | 78,193 | Mar 11 |
| Linett Mat | Senior Managing Director | Mar 06 '26 | Buy | 13.05 | 2,000 | 26,099 | 10,365 | Mar 06 |
| McCally John | Vice President & Secretary | Mar 05 '26 | Buy | 13.30 | 2,000 | 26,595 | 7,430 | Mar 06 |
| Strife Jason | Member-Sub-Adv's Joint Inv Com | Mar 04 '26 | Buy | 13.40 | 7,690 | 103,046 | 15,737 | Mar 06 |
| Kencel Kenneth J. | CEO & President | Mar 03 '26 | Buy | 13.04 | 20,000 | 260,768 | 58,117 | Mar 05 |
| Miranda Kenneth M. | Director | Mar 03 '26 | Buy | 12.83 | 3,000 | 38,490 | 30,000 | Mar 05 |
| Miranda Kenneth M. | Director | Nov 19 '25 | Buy | 14.10 | 2,000 | 28,200 | 27,000 | Nov 21 |
| Vichness Shaul | Chief Financial Off./Treasurer | Nov 17 '25 | Buy | 14.20 | 5,000 | 71,000 | 20,000 | Nov 17 |
| Kencel Kenneth J. | CEO & President | Nov 06 '25 | Buy | 14.22 | 20,000 | 284,400 | 48,117 | Nov 07 |
| Vichness Shaul | Chief Financial Off./Treasurer | Sep 16 '25 | Buy | 14.85 | 5,000 | 74,250 | 15,000 | Sep 16 |